Buy Dasatinib Online

Dasatinib is an oral tyrosine kinase inhibitor used for certain Philadelphia chromosome–positive leukemias. It can be ordered through licensed pharmacy channels, with the dose or strength selected to match the directions from your oncology care team. Current Dasatinib price information, strength choices, and quantity choices can help you plan treatment expenses before checkout.

This medicine is best known by the brand name Sprycel. Many people compare Dasatinib cost, Sprycel price, and cash-pay options because treatment may continue for an extended period. BorderFreeHealth provides U.S. delivery from Canada for eligible medication orders through licensed pharmacies, and order details may be checked for accuracy before the pharmacy prepares the medicine.

Dasatinib Price, Strength Selection, and Ordering

Dasatinib pricing depends on the strength, quantity, manufacturer source, and whether the order is for generic dasatinib or a brand-name dasatinib product such as Sprycel. The product ordering area shows the current price before payment, so you can align the quantity with your treatment plan and budget. If you are paying without insurance, reviewing the per-fill total and the approximate Dasatinib cost per pill may make monthly planning easier.

Select the tablet strength shown during ordering only if it matches the directions from your cancer care team. Existing marketed strengths include 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg tablets, although supplier availability can vary. Common searches such as Dasatinib 70mg tablets, Dasatinib 100mg tablets, Sprycel 70mg, and Sprycel 100mg tablets reflect strength decisions that should be driven by diagnosis, treatment phase, lab results, and the official label.

Quick tip: Keep the medication name, strength, daily schedule, and quantity together when you place an order so the pharmacy can match the order to the treatment directions.

What Dasatinib Treats

Dasatinib is used for Philadelphia chromosome–positive chronic myeloid leukemia, often shortened to Ph+ CML. CML is a blood and bone marrow cancer linked to an abnormal BCR-ABL1 signal that tells white blood cells to grow in an uncontrolled way. You can learn more about the condition through our chronic myeloid leukemia information.

The medicine is also used in certain people with Philadelphia chromosome–positive acute lymphoblastic leukemia, or Ph+ ALL. ALL is a faster-growing leukemia, and the Philadelphia chromosome can influence treatment choice. For disease background, see our Philadelphia chromosome-positive acute lymphoblastic leukemia information.

Treatment suitability depends on the leukemia type, phase of disease, previous therapies, other medical conditions, and tolerability. Your oncology team may monitor blood counts, response markers, heart or lung symptoms, and organ function during therapy. Do not start, stop, or change the dose without medical guidance.

How This Targeted Cancer Medicine Works

Dasatinib belongs to a class called tyrosine kinase inhibitors, or TKIs. It is not traditional chemotherapy in the older sense of broadly attacking fast-dividing cells. Instead, it targets specific abnormal signaling pathways, especially BCR-ABL1, that help drive Philadelphia chromosome–positive leukemia cell growth.

The active ingredient binds to the ATP-binding site of BCR-ABL1 and reduces downstream signals that support cancer cell division. It also inhibits Src family kinases. By blocking these pathways, the medicine can help control leukemia activity and support hematologic or cytogenetic responses when used as directed and monitored appropriately.

Targeted does not mean risk-free. TKIs can still affect normal cells and body systems, which is why regular laboratory monitoring matters. Blood counts, symptoms, treatment response, and medication interactions all influence whether therapy continues unchanged or needs adjustment.

How to Take the Tablets

Follow the official label and the schedule given by your oncology team. Dasatinib is generally taken once daily, with or without food. Swallow tablets whole with water. Do not crush, split, or chew them, because broken tablets can expose skin or caregivers to medication powder.

If a tablet is damaged, avoid direct contact with the powder and ask a healthcare professional or pharmacist about safe handling and disposal. Caregivers should wash hands after handling the container. The medicine should be taken consistently, because missed or irregular doses may affect treatment control.

If you miss a dose, follow the product label or your care team’s instructions. In general, do not take two doses at the same time to make up for a missed tablet. A daily reminder, pill-tracking sheet, or phone alarm can help keep treatment on schedule.

Food, Drinks, and Absorption Issues

Grapefruit and grapefruit juice should be avoided because they can affect CYP3A4 activity and may raise dasatinib exposure. That higher exposure can increase the chance of side effects. If you are unsure whether a fruit juice or supplement contains grapefruit-related ingredients, ask a pharmacist before using it.

Acid-reducing medicines need special attention. Proton pump inhibitors and H2 blockers can lower dasatinib absorption and may reduce its effect. Antacids may need to be separated from the dose according to the official label. Tell your care team about heartburn medicines, calcium products, magnesium products, and over-the-counter remedies.

Alcohol is not a direct food interaction in the same way as grapefruit, but it may matter if you have liver concerns, bleeding risk, nausea, or fatigue. Discuss alcohol intake with your care team so the advice fits your medical history and laboratory results.

Side Effects, Warnings, and Monitoring

Common side effects may include headache, tiredness, nausea, vomiting, diarrhea, rash, itching, muscle pain, joint pain, and fluid retention. Some people notice swelling in the hands, ankles, or around the eyes. Report side effects early, because supportive care or monitoring changes may help reduce treatment disruption.

Low blood counts are an important safety concern. Dasatinib can cause anemia, neutropenia, and thrombocytopenia. These changes may increase fatigue, infection risk, or bleeding risk. Regular blood tests help your team identify problems before they become severe.

Serious risks can include pleural effusion, pulmonary arterial hypertension, severe bleeding, infections, QT prolongation, cardiovascular events, and liver problems. Contact a healthcare professional urgently for shortness of breath, chest pain, fainting, rapid weight gain, severe dizziness, fever, unusual bruising, black stools, coughing blood, or yellowing of the skin or eyes.

Extra caution may be needed for people with prior lung problems, heart rhythm concerns, uncontrolled cardiovascular disease, significant liver disease, a history of bleeding, or very low baseline blood counts. Pregnancy and breastfeeding require medical discussion because anticancer medicines may harm a developing baby or nursing infant.

Drug Interactions to Review Before Use

Strong CYP3A4 inhibitors can raise dasatinib levels. Examples may include certain azole antifungals, macrolide antibiotics, HIV medicines, and other drugs that affect the same pathway. Higher levels may increase risks such as low blood counts, fluid retention, or bleeding.

Strong CYP3A4 inducers can lower dasatinib levels and may reduce effectiveness. Examples may include rifampin, certain seizure medicines, and St. John’s wort. Herbal products matter, so include supplements when you share your medication list.

Blood thinners, antiplatelet medicines, nonsteroidal anti-inflammatory drugs, and other treatments that increase bleeding risk may require closer monitoring. QT-prolonging medicines can also matter in people with rhythm concerns. Ask your oncology team or pharmacist to review all prescription medicines, over-the-counter products, vitamins, and herbs before combining them with dasatinib.

Storage, Travel, and Handling

Store tablets at room temperature in the original container, closed tightly, and protected from moisture. Keep the medicine away from children and pets. Avoid bathroom storage because heat and humidity may affect medication quality.

For travel, keep tablets in carry-on luggage with the pharmacy label intact. Bring a medication list and a copy of treatment instructions when possible. If you cross time zones, ask your care team how to keep a consistent once-daily schedule.

Do not transfer tablets into an unmarked container for international travel. If the itinerary changes unexpectedly, protect the medicine from extreme heat, cold, and moisture. Orders may include prompt, express shipping, but ongoing treatment should be planned early enough to avoid running out.

Benefits and Practical Expectations

Dasatinib offers targeted oral treatment for leukemias driven by the Philadelphia chromosome. Many people value once-daily dosing and the ability to take it with or without meals. The product also gives oncology teams measurable treatment markers to follow over time.

Response is assessed through scheduled blood tests and disease-specific monitoring. Early blood count changes may occur before deeper molecular or cytogenetic assessments. Some side effects, such as fatigue or mild fluid retention, may appear earlier in treatment, while lung symptoms should always be reported promptly.

Long-term use requires partnership with your care team. Keeping lab appointments, reporting symptoms, and maintaining a reliable refill routine all support safer therapy. If treatment goals are not being met, your clinician may discuss another TKI or a different strategy.

Brand, Generic, and Related Treatment Choices

Sprycel is the brand name for dasatinib. Generic dasatinib contains the same active ingredient, but product names, manufacturers, pricing, and market availability can differ by country. If you are comparing Generic dasatinib price with Sprycel cost, make sure the strength and quantity are the same.

Other TKIs may be used for related leukemia situations, including imatinib, bosutinib, nilotinib, or asciminib. The best choice depends on disease phase, prior response, mutation testing when performed, other medical conditions, and interaction risks. Broader treatment browsing is available in our cancer medication category.

For education beyond this medicine, the cancer articles section covers related treatment and condition topics. These materials can help you prepare questions, but treatment decisions should be based on your own diagnosis and oncology plan.

Questions to Ask Your Oncology Team

• Which strength and schedule should match my current treatment plan?
• How often should blood counts, liver tests, and response markers be checked?
• Which symptoms mean I should call urgently?
• Should I avoid grapefruit, acid reducers, supplements, or certain antibiotics?
• How should missed doses, travel, or treatment holds be handled?
• What side effects are expected, and which ones are warning signs?
• Could another TKI be considered if tolerability or response becomes a concern?

Authoritative Sources

Official prescribing information for Sprycel

Health Canada product record

This content is for informational purposes only and is not a substitute for professional medical advice.